Effectiveness of Hypoglycemic Medications Among Veterans with CKD
Congressional District Code:
Clinical Science R&D
October 2020 -
FY 2021 Funding Amount:
Total Award Amount (all years):
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt:
Approximately 30 million adults have diabetes (DM) in the United States and DM confers a risk for cardiovascular disease (CVD). Whether CVD is prevented by antidiabetic therapies which target glycemic control remains relatively unknown. Between 2013-2017 there were multiple pivotal trials of newer agent called sodium–glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP1RA) vs placebo. These newer agents demonstrated reduction in CVD and kidney outcomes. T...